Skip to main content
Log in

Protective Effect of 1,25-Dihydroxy Vitamin D3 on Pepsin–Trypsin-Resistant Gliadin-Induced Tight Junction Injuries

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

Tight junction (TJ) injuries induced by pepsin–trypsin-resistant gliadin (PT–G) play an important role in the pathogenesis of celiac disease. Previously, 1,25-dihydroxy vitamin D3 (VD3) was reported to be a TJ regulator that attenuates lipopolysaccharide- and alcohol-induced TJ injuries. However, whether VD3 can attenuate PT–G-induced TJ injuries is unknown.

Aim

The aim of this study was to evaluate the effects of VD3 on PT–G-induced TJ injuries.

Methods

Caco-2 monolayers were used as in vitro models. After being cultured for 21 days, the monolayers were treated with PT–G plus different concentrations of VD3. Then, the changes in trans-epithelial electrical resistance and FITC-dextran 4000 (FD-4) flux were determined to evaluate the monolayer barrier function. TJ protein levels were measured to assess TJ injury severity, and myeloid differentiation factor 88 (MyD88) expression and zonulin release levels were determined to estimate zonulin release signaling pathway activity. Additionally, a gluten-sensitized mouse model was established as an in vivo model. After the mice were treated with VD3 for 7 days, we measured serum FD-4 concentrations, TJ protein levels, MyD88 expression, and zonulin release levels to confirm the effect of VD3.

Results

Both in vitro and in vivo, VD3 significantly attenuated the TJ injury-related increase in intestinal mucosa barrier permeability. Moreover, VD3 treatment up-regulated TJ protein expression levels and significantly decreased MyD88 expression and zonulin release levels.

Conclusions

VD3 has protective effects against PT–G-induced TJ injuries both in vitro and in vivo, which may correlate with the disturbance of the MyD88-dependent zonulin release signaling pathway.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Kang JY, Kang AH, Green A, Gwee KA, Ho KY. Systematic review: Worldwide variation in the frequency of coeliac disease and changes over time. Aliment Pharmacol Ther. 2013;38:226–245.

    Article  CAS  PubMed  Google Scholar 

  2. Caminero A, Galipeau HJ, McCarville JL, et al. Duodenal bacteria from patients with celiac disease and healthy subjects distinctly affect gluten breakdown and immunogenicity. Gastroenterology. 2016;151:670–683.

    Article  CAS  PubMed  Google Scholar 

  3. Maiuri L, Ciacci C, Ricciardelli I, et al. Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet. 2003;362:30–37.

    Article  CAS  PubMed  Google Scholar 

  4. Almeida LM, Gandolfi L, Pratesi R, et al. Presence of DQ2.2 associated with DQ2.5 increases the risk for celiac disease. Autoimmune Dis. 2016;2016:5409653.

    PubMed  PubMed Central  Google Scholar 

  5. Lammers KM, Khandelwal S, Chaudhry F, et al. Identification of a novel immunomodulatory gliadin peptide that causes interleukin-8 release in a chemokine receptor CXCR3-dependent manner only in patients with coeliac disease. Immunology. 2011;132:432–440.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Lammers KM, Lu R, Brownley J, et al. Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. Gastroenterology. 2008;135:194.e3–204.e3.

    Google Scholar 

  7. Sturgeon C, Fasano A. Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases. Tissue Barriers. 2016;4:e1251384.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Fasano A. Intestinal permeability and its regulation by zonulin: diagnostic and therapeutic implications. Ann N Y Acad Sci. 2012;1258:25–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Sapone A, de Magistris L, Pietzak M, et al. Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives. Diabetes. 2006;55:1443–1449.

    Article  CAS  PubMed  Google Scholar 

  10. Vanuytsel T, Vermeire S, Cleynen I. The role of Haptoglobin and its related protein, Zonulin, in inflammatory bowel disease. Tissue Barriers. 2013;1:e27321.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Chiba H, Osanai M, Murata M, Kojima T, Sawada N. Transmembrane proteins of tight junctions. Biochim Biophys Acta. 2008;1778:588–600.

    Article  CAS  PubMed  Google Scholar 

  12. Thomas KE, Sapone A, Fasano A, Vogel SN. Gliadin stimulation of murine macrophage inflammatory gene expression and intestinal permeability are MyD88-dependent: role of the innate immune response in Celiac disease. J Immunol. 2006;176:2512–2521.

    Article  CAS  PubMed  Google Scholar 

  13. Chung BH, Kim BM, Doh KC, et al. Suppressive effect of 1α,25-dihydroxyvitamin D3 on Th17-immune responses in kidney transplant recipients with tacrolimus-based immunosuppression. Transplantation. 2016;101:1711.

    Article  Google Scholar 

  14. Li M, Li L, Zhang L, et al. 1,25-Dihydroxyvitamin D3 suppresses gastric cancer cell growth through VDR- and mutant p53-mediated induction of p21. Life Sci. 2017;179:88.

    Article  CAS  PubMed  Google Scholar 

  15. Kim SH, Pei QM, Jiang P, Yang M, Qian XJ, Liu JB. Effect of active vitamin D3 on VEGF-induced ADAM33 expression and proliferation in human airway smooth muscle cells: implications for asthma treatment. Respir Res. 2017;18:7.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Dai ZH, Tan B, Yang H, Wang O, Qian JM, Lv H. 1,25-Hydroxyvitamin D relieves colitis in rats via down-regulation of toll-like receptor 9 expression. Croat Med J. 2015;56:515–524.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Zhao H, Zhang H, Wu H, et al. Protective role of 1,25(OH)2 vitamin D3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice. BMC Gastroenterol. 2012;30:57.

    Article  Google Scholar 

  18. Chen S, Zhu J, Chen G, et al. 1,25-Dihydroxyvitamin D3 preserves intestinal epithelial barrier function from TNF-α induced injury via suppression of NF-kB p65 mediated MLCK-P-MLC signaling pathway. Biochem Biophys Res Commun. 2015;460:873–878.

    Article  CAS  PubMed  Google Scholar 

  19. Chen SW, Ma YY, Zhu J, et al. Protective effect of 1,25-dihydroxyvitamin D3 on ethanol-induced intestinal barrier injury both in vitro and in vivo. Toxicol Lett. 2015;237:79–88.

    Article  CAS  PubMed  Google Scholar 

  20. Jiang J, Shi D, Zhou XQ, et al. Vitamin D inhibits lipopolysaccharide-induced inflammatory response potentially through the Toll-like receptor 4 signalling pathway in the intestine and enterocytes of juvenile Jian carp (Cyprinus carpio var. Jian). Br J Nutr. 2015;114:1560–1568.

    Article  CAS  PubMed  Google Scholar 

  21. Li B, Baylink DJ, Deb C, et al. 1,25-Dihydroxyvitamin D3 suppresses TLR8 expression and TLR8-mediated inflammatory responses in monocytes in vitro and experimental autoimmune encephalomyelitis in vivo. PLoS ONE. 2013;8:e58808.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Equils O, Naiki Y, Shapiro AM, et al. 1,25-Dihydroxyvitamin D inhibits lipopolysaccharide-induced immune activation in human endothelial cells. Clin Exp Immunol. 2006;143:58–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Gujral N, Suh JW, Sunwoo HH. Effect of anti-gliadin IgY antibody on epithelial intestinal integrity and inflammatory response induced by gliadin. BMC Immunol. 2015;9:41.

    Article  Google Scholar 

  24. Guo S, Al-Sadi R, Said HM, Ma TY. Lipopolysaccharide causes an increase in intestinal tight junction permeability in vitro and in vivo by inducing enterocyte membrane expression and localization of TLR-4 and CD14. Am J Pathol. 2013;182:375–387.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Papista C, Gerakopoulos V, Kourelis A, et al. Gluten induces coeliac-like disease in sensitised mice involving IgA, CD71 and transglutaminase 2 interactions that are prevented by probiotics. Lab Invest. 2012;92:625–635.

    Article  CAS  PubMed  Google Scholar 

  26. Huber M, Baier W, Bessler WG, Heinevetter L. Modulation of the Th1/Th2 bias by lipopeptide and saponin adjuvants in orally immunized mice. Immunobiology. 2002;205:61–73.

    Article  CAS  PubMed  Google Scholar 

  27. Gourbeyre P, Denery-Papini S, Larré C, Gaudin JC, Brossard C, Bodinier M. Wheat gliadins modified by deamidation are more efficient than native gliadins in inducing a Th2 response in Balb/c mice experimentally sensitized to wheat allergens. Mol Nutr Food Res. 2012;56:336–344.

    Article  CAS  PubMed  Google Scholar 

  28. Everard A, Geurts L, Caesar R, et al. Intestinal epithelial MyD88 is a sensor switching host metabolism towards obesity according to nutritional status. Nat Commun. 2014;5:5648.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Gopalakrishnan S, Durai M, Kitchens K, et al. Larazotide acetate regulates epithelial tight junctions in vitro and in vivo. Peptides. 2012;35:86–94.

    Article  CAS  PubMed  Google Scholar 

  30. Khaleghi S, Ju JM, Lamba A, Murray JA. The potential utility of tight junction regulation in celiac disease: focus on larazotide acetate. Therap Adv Gastroenterol. 2016;9:37–49.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Leffler DA, Kelly CP, Green PH, et al. Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: a randomized controlled trial. Gastroenterology. 2015;148:1311.e6–1319.e6.

    Article  Google Scholar 

  32. Leffler DA, Kelly CP, Abdallah HZ, et al. A randomized, double-blind study of larazotide acetate to prevent the activation of celiac disease during gluten challenge. Am J Gastroenterol. 2012;107:1554–1562.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Lange TS, Stuckey AR, Robison K, et al. Effect of a vitamin D3 derivative (B3CD) with postulated anti-cancer activity in an ovarian cancer animal model. Investig New Drugs. 2010;28:543–553.

    Article  CAS  Google Scholar 

  34. Gui B, Chen Q, Hu C, Zhu C, He G. Effects of calcitriol (1,25-dihydroxy-vitamin D3) on the inflammatory response induced by H9N2 influenza virus infection in human lung A549 epithelial cells and in mice. Virol J. 2017;14:10.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Orlando A, Linsalata M, Notarnicola M, Tutino V, Russo F. Lactobacillus GG restoration of the gliadin induced epithelial barrier disruption: The role of cellular polyamines. BMC Microbiol. 2014;14:19.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Datta P, Weis MT. Calcium glycerophosphate preserves transepithelial integrity in the Caco-2 model of intestinal transport. WJG. 2015;21:9055–9066.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Barilli A, Rotoli BM, Visigalli R, et al. Gliadin-mediated production of polyamines by RAW264.7 macrophages modulates intestinal epithelial permeability in vitro. Biochim Biophys Acta. 2015;1852:1779–1786.

    Article  CAS  PubMed  Google Scholar 

  38. Dormoy V, Béraud C, Lindner V, et al. Vitamin D3 triggers antitumor activity through targeting hedgehog signaling in human renal cell carcinoma. Carcinogenesis. 2012;33:2084–2093.

    Article  CAS  PubMed  Google Scholar 

  39. Chen S, Zhu J, Zuo S, et al. 1,25(OH)2D3 attenuates TGF-β1/β2-induced increased migration and invasion via inhibiting epithelial-mesenchymal transition in colon cancer cells. Biochem Biophys Res Commun. 2015;468:130–135.

    Article  CAS  PubMed  Google Scholar 

  40. Aggarwal A, Kállay E. Cross talk between the calcium-sensing receptor and the vitamin D system in prevention of cancer. Front Physiol. 2016;7:451. (eCollection 2016).

    Article  PubMed  PubMed Central  Google Scholar 

  41. Abe R, Shimizu S, Yasuda K, et al. Evaluation of reduced allergenicity of deamidated gliadin in a mouse model of wheat-gliadin allergy using an antibody prepared by a peptide containing three epitopes. J Agric Food Chem. 2014;62:2845–2852.

    Article  CAS  PubMed  Google Scholar 

  42. Silva MA, Jury J, Sanz Y, et al. Increased bacterial translocation in gluten-sensitive mice is independent of small intestinal paracellular permeability defect. Dig Dis Sci. 2012;57:38–47. doi:10.1007/s10620-011-1847-z.

    Article  CAS  PubMed  Google Scholar 

Download references

Author’s contribution

SD performed the majority of the experiments. XW and HY performed the animal experiments and analyzed the data. HW and TPS designed the research. SD, TPS, and HW wrote the paper.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hongling Wang.

Ethics declarations

Conflict of interest

All the authors declare that there are no conflict of interests for this article.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dong, S., Singh, T.P., Wei, X. et al. Protective Effect of 1,25-Dihydroxy Vitamin D3 on Pepsin–Trypsin-Resistant Gliadin-Induced Tight Junction Injuries. Dig Dis Sci 63, 92–104 (2018). https://doi.org/10.1007/s10620-017-4738-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-017-4738-0

Keywords

Navigation